Sagimet Biosciences, Inc. Class A's market cap is currently $124.54M. The company's EPS TTM is $-1.293; its P/E ratio is ―; Sagimet Biosciences, Inc. Class A is scheduled to report earnings on March 31, 2025, and the estimated EPS forecast is $-0.61. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 2.00M	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ 2.00M	$ -130.00K	$ -134.00K	$ -124.00K	$ -88.00K
Operating Income	$ -30.74M	$ -31.05M	$ -23.72M	$ -11.40M	$ -14.25M
EBITDA	$ -30.74M	$ -30.37M	$ -24.31M	$ -11.25M	$ -14.11M
Net Income	$ -27.88M	$ -30.50M	$ -24.44M	$ -11.37M	$ -14.26M
Balance Sheet
Cash & Short-Term Investments	$ 94.90M	$ 32.34M	$ 56.73M	$ 68.70M	$ 10.21M
Total Assets	$ 96.72M	$ 33.03M	$ 59.03M	$ 68.96M	$ 11.16M
Total Debt	$ 65.00K	$ 211.00K	$ 348.00K	$ 210.00K	$ 341.00K
Net Debt	$ -75.07M	$ 53.00K	$ -56.38M	$ -68.49M	$ -9.87M
Total Liabilities	$ 5.65M	$ 219.98M	$ 217.29M	$ 204.87M	$ 136.47M
Stockholders' Equity	$ 91.06M	$ -186.95M	$ -158.26M	$ -135.91M	$ -125.31M
Cash Flow
Free Cash Flow	$ -23.77M	$ -24.49M	$ -21.71M	$ -10.42M	$ -10.55M
Operating Cash Flow	$ -23.77M	$ -24.49M	$ -21.71M	$ -10.42M	$ -10.55M
Investing Cash Flow	$ 12.58M	$ -32.01M	$ 0.00	$ 20.00K	$ -27.00K
Financing Cash Flow	$ 86.17M	$ -73.00K	$ 9.74M	$ 68.89M	$ 18.48M

Currency in USD

Sagimet Biosciences, Inc. Class A Earnings and Revenue History

Income Statement >

Sagimet Biosciences, Inc. Class A Debt to Assets

Balance Sheet >

Sagimet Biosciences, Inc. Class A Cash Flow

Cash Flow >

Sagimet Biosciences, Inc. Class A Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing